Thursday, 20 October 2022
The ICN2 and CSIC are partnering with Art-lens to develop better ocular prosthetic solutions for patients that have lost an eye. From the ICN2 side, the project will be led by Dr Claudio Roscini from the Nanosfun group.
Thursday, 06 October 2022
Dr Gerardo Marchesini opens a new series of seminars launched by the ICN2 Department of Business and Innovation. He shared his experience with deeptech technology and startup companies in a lecture held on October 4.
Tuesday, 22 February 2022
A European Forum for Science, Technology and Innovation, “Transfiere” was held in Malaga on February 16-17.
Tuesday, 15 March 2022
INBRAIN Neuroelectronics is a technology company developing graphene-based applications for neurological diseases founded by researchers from IMB-CNM-CSIC, ICN2 and ICREA who lead some of the research areas of the Graphene Flagship. The agreement paves the way for further development and industrialization of patented technology from CSIC, ICN2, ICREA, CIBERBBN, UAB and IDIBAPS.
Monday, 14 February 2022
The “BioRegió” Report 2021 provides data about the new health-related companies created from Catalan universities and research institutes in the last year. The ICN2 is well positioned, with 6 start-ups and 17.4 millions of euros invested in them.
